Research Triangle-based StrideBio, a startup focusing on gene editing technology, inked a deal with Massachusetts-based Sarepta Therapeutics for a deal worth nearly $90 million plus future potential royalties based on rights to as many as eight potential gene-based...
AAV
Category
The Evolving Field of AAV-Based Gene Therapies
Gene therapy is evolving past R&D phases with the emergence of new AAV-based gene therapies and a substantial increase in companies participating in gene therapy clinical work. TrialSite News summarizes recent progressions in the field that were reported in...